JP2022501031A5 - - Google Patents

Info

Publication number
JP2022501031A5
JP2022501031A5 JP2021515177A JP2021515177A JP2022501031A5 JP 2022501031 A5 JP2022501031 A5 JP 2022501031A5 JP 2021515177 A JP2021515177 A JP 2021515177A JP 2021515177 A JP2021515177 A JP 2021515177A JP 2022501031 A5 JP2022501031 A5 JP 2022501031A5
Authority
JP
Japan
Prior art keywords
car
cells
culture
modified immune
immune cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021515177A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022501031A (ja
JP7716976B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051832 external-priority patent/WO2020061256A1/en
Publication of JP2022501031A publication Critical patent/JP2022501031A/ja
Publication of JP2022501031A5 publication Critical patent/JP2022501031A5/ja
Priority to JP2025044165A priority Critical patent/JP2025106298A/ja
Application granted granted Critical
Publication of JP7716976B2 publication Critical patent/JP7716976B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515177A 2018-09-19 2019-09-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ Active JP7716976B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025044165A JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862733291P 2018-09-19 2018-09-19
US62/733,291 2018-09-19
PCT/US2019/051832 WO2020061256A1 (en) 2018-09-19 2019-09-19 Protein l for activation and expansion of chimeric antigen receptor-modified immune cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025044165A Division JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Publications (3)

Publication Number Publication Date
JP2022501031A JP2022501031A (ja) 2022-01-06
JP2022501031A5 true JP2022501031A5 (https=) 2022-08-12
JP7716976B2 JP7716976B2 (ja) 2025-08-01

Family

ID=68085017

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021515177A Active JP7716976B2 (ja) 2018-09-19 2019-09-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ
JP2025044165A Withdrawn JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025044165A Withdrawn JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Country Status (10)

Country Link
US (1) US12533414B2 (https=)
EP (1) EP3853351A1 (https=)
JP (2) JP7716976B2 (https=)
KR (1) KR20210061397A (https=)
CN (1) CN112739816B (https=)
AU (1) AU2019345052B2 (https=)
CA (1) CA3110706A1 (https=)
IL (1) IL281413B2 (https=)
SG (1) SG11202102654UA (https=)
WO (1) WO2020061256A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL297697A (en) * 2020-06-17 2022-12-01 Tiziana Life Sciences Plc Preparations and methods for improving chimeric antigen receptor t cell therapies
WO2022216624A1 (en) 2021-04-07 2022-10-13 Century Therapeutics, Inc. Compositions and methods for generating alpha-beta t cells from induced pluripotent stem cells
BR112023018844A2 (pt) 2021-04-07 2023-10-10 Century Therapeutics Inc Composições e métodos para geração de células t gama-delta de células-tronco pluripotentes induzidas
JP7738826B2 (ja) * 2021-10-29 2025-09-16 東ソー株式会社 遺伝子改変ｔ細胞の製造方法
CN113980901B (zh) * 2021-12-28 2022-06-17 上海惠盾因泰生物科技有限公司 一种制备高纯度的成熟人树突状细胞的方法及应用
EP4717765A1 (en) * 2023-05-22 2026-04-01 Kyoto University Method for producing cell population containing cd4 single positive helper t cells from pluripotent stem cells

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1147186A4 (en) 1999-01-28 2002-05-15 Palmetto Health Alliance D B A In vitro activated gamma delta lymphocytes
US20030235908A1 (en) 2000-02-24 2003-12-25 Xcyte Therapies, Inc. Activation and expansion of cells
CA2534639C (en) 2003-07-31 2013-07-30 Immunomedics, Inc. Anti-cd19 antibodies
JP5156382B2 (ja) * 2005-09-30 2013-03-06 タカラバイオ株式会社 Ｔ細胞集団の製造方法
US20110158954A1 (en) * 2007-03-09 2011-06-30 Mitsuko Ideno Method for producing gamma delta t cell population
EP2267118A4 (en) * 2008-03-27 2013-08-28 Takara Bio Inc METHOD FOR PRODUCING A TRANSFICED CELL
KR101720961B1 (ko) 2009-02-27 2017-03-29 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 다능성 세포의 분화
JP6509724B2 (ja) 2012-04-20 2019-05-08 アプティーボ リサーチ アンド デベロップメント エルエルシー Ｃｄ３結合ポリペプチド
CN102816734A (zh) 2012-05-09 2012-12-12 阮润生 一种肿瘤抗原特异性t细胞的获取方法
MX370148B (es) 2012-10-02 2019-12-03 Memorial Sloan Kettering Cancer Center Composiciones y su uso para inmunoterapia.
JP6961490B2 (ja) * 2015-04-08 2021-11-05 ノバルティス アーゲー Ｃｄ２０療法、ｃｄ２２療法、およびｃｄ１９キメラ抗原受容体（ｃａｒ）発現細胞との併用療法
WO2017050428A1 (en) * 2015-09-25 2017-03-30 Flechsig Patent Company Llc Novel plant protecting compositions and uses thereof
US10947502B2 (en) 2015-10-20 2021-03-16 FUJIFILM Cellular Dynamics, Inc. Methods for directed differentiation of pluripotent stem cells to immune cells
SG11201803419PA (en) 2015-10-30 2018-05-30 The Regents Of The Universtiy Of California Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells
SG11201803145RA (en) * 2015-11-04 2018-05-30 Fate Therapeutics Inc Methods and compositions for inducing hematopoietic cell differentiation
WO2017079400A1 (en) 2015-11-04 2017-05-11 The Trustees Of The University Of Pennsylvania Methods and compositions for gene editing in hematopoietic stem cells
JP7016098B2 (ja) * 2016-03-16 2022-02-21 ネクシミューン インコーポレイテッド 抗原特異的ｔ細胞の生成
EP3548055A4 (en) * 2016-12-02 2020-08-19 University of Southern California SYNTHETIC IMMUNE RECEPTORS AND THEIR PROCESSES FOR USE
JPWO2021200901A1 (https=) * 2020-03-31 2021-10-07

Similar Documents

Publication Publication Date Title
JP2022501031A5 (https=)
MacDonald et al. Methods to manufacture regulatory T cells for cell therapy
Knorr et al. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy
CN107922925B (zh) 用于自然杀伤细胞扩增的方法
US8071374B2 (en) Methods for preparing T-cells for cell therapy
US20220016172A1 (en) Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
Shimasaki et al. Expanded and armed natural killer cells for cancer treatment
Angoulvant et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.
CN108473959B (zh) 用来在过继性免疫疗法中进行免疫细胞调节的组合物和方法
JP2020517237A5 (https=)
CN107002039B (zh) 使用t细胞用于培养自然杀伤细胞的方法
Ye et al. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
JP2023516632A5 (https=)
JP2018515108A (ja) 準静的細胞培養
CN102428173A (zh) Nk细胞的扩增
US20210371820A1 (en) Method for amplifying antigen-specific regulatory t cells in vitro
CN115491354B (zh) 一种nk细胞分化的方法
Li et al. Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells
Good et al. Using human induced pluripotent stem cells for the generation of tumor antigen-specific T cells
US20040147021A1 (en) CD4+CD25 T cells and Tr1-like regulatory T cells
JP2025502150A5 (https=)
JP2024523332A5 (https=)
CN102802686A (zh) 骨髓胞外基质提取物及其治疗用途
Williams et al. In vitro T lymphopoiesis: iPSCs for T cell generation, foundations, innovations, and future directions
HK40064965A (en) Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions